<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01326390</url>
  </required_header>
  <id_info>
    <org_study_id>HEP0035</org_study_id>
    <secondary_id>SU-07012010-6469</secondary_id>
    <nct_id>NCT01326390</nct_id>
  </id_info>
  <brief_title>Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma</brief_title>
  <official_title>Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Impact on contrast dose or total volume of contrast required to effectively treat the
      targeted tumor.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients that develop renal failure (defined as a decline of renal function, as measured by glomerular filtration rate, of 25% or more from pre-procedural)</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">13</enrollment>
  <condition>Kidney (Renal Cell) Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dTA/dBA C-arm fluoroscopy system with Dyna CT</intervention_name>
    <description>C-arm CT of the liver; state-of-the-art flat panel detector on a ceiling or floor mounted C-arm gantry</description>
    <other_name>X-ray image intensifier</other_name>
    <other_name>Siemens Angiography systems</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DSA arteriogram- hepatic arteries</intervention_name>
    <description>Standard of care</description>
    <other_name>Angiography</other_name>
    <other_name>arteriography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 aortogram</intervention_name>
    <description>Standard of care</description>
    <other_name>Aortography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients we are seeking will already have been scheduled to undergo liver Transhepatic
        arterial chemoembolizationWorld Health Organization treatment using C-arm CT as the imaging
        guidance (with limited Digital Subtraction angiography as needed).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients must be affected by HCC

          2. Patients must have diminished renal function (GFR&lt;60 ml/min/1.73m^2)

          3. Patients must be 18 years old or older

          4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to
             the TACE procedure.

          5. Ability to understand and the willingness to sign a written informed consent document.

        Exclusion Criteria:

          1. Subjects under the age of 18

          2. Patients currently on dialysis

          3. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nishita N. Kothary</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2010</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2011</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

